Early response to combination therapy (interferon [IFN] and ribavirin [RIBI]) for treatment of patients with inherited coagulation disorders and chronic hepatitis C
T. Abshire, Early response to combination therapy (interferon [IFN] and ribavirin [RIBI]) for treatment of patients with inherited coagulation disorders and chronic hepatitis C, HAEMOPHILIA, 6, 2000, pp. 21-22